Xenical is a drug owned by Cheplapharm Arzneimittel Gmbh. It is protected by 2 US drug patents filed in 2013 out of which all have expired. Based on its patents and exclusivities, its generic launch date is estimated to be Jul 06, 2018. Details of Xenical's patents and their expiration are given in the table below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| These drug patents focus on the other aspects of the drug like dosage, mode of administration (oral, tablet, capsules, liquids etc). | |||
|
US6004996 (Pediatric) | Tetrahydrolipstatin containing compositions |
Jul, 2018
(6 years ago) |
Expired
|
| US6004996 | Tetrahydrolipstatin containing compositions |
Jan, 2018
(6 years ago) |
Expired
|
US patents provide insights into the exclusivity only within the United States, but Xenical is protected by patents in multiple countries. Understanding the full scope of patent protection is crucial in strategizing market entry. By looking at the broader patent landscape, you can identify markets with weaker patent protection which could be ideal generic entry points. The following section offers details on Xenical's family patents as well as insights into ongoing legal events on those patents.
Xenical's Family Patents
Explore Our Curated Drug Screens
Generic Launch
Generic Release Date:
Xenical's generic launch date based on the expiry of its last outstanding patent is estimated to be Jul 06, 2018 (This date is subject to change depending upon the patent filing activities by the drug owner or exclusivity additions to its drug application)
Xenical Generics:
There are no approved generic versions for Xenical as of now.
Alternative Brands for Xenical
There are several other brand drugs using the same active ingredient (Orlistat) as Xenical. Given below is the list of those companies and their brand drugs, to help you identify new opportunities, assess competitors, and plan your market strategies more effectively.
| Drug Owner | Drug Name | |
|---|---|---|
| Haleon Us Holdings |
|
About Xenical
Xenical is a drug owned by Cheplapharm Arzneimittel Gmbh. Xenical uses Orlistat as an active ingredient. Xenical was launched by Cheplapharm in 1999.
Approval Date:
Xenical was approved by FDA for market use on 23 April, 1999.
Active Ingredient:
Xenical uses Orlistat as the active ingredient. Check out other Drugs and Companies using Orlistat ingredient
Dosage:
Xenical is available in capsule form for oral use. Given below is detailed information on Dosage -
| Strength | Dosage Form | Availability | Application Pathway |
|---|---|---|---|
| 120MG | CAPSULE | Prescription | ORAL |